ClinicalTrials.gov
Official API · multinational records · source links on every study
Official registry discovery
Global Phase I-III
drug opportunity library.
Discover active drug and biologic programs, trace every record to its official source, and prioritize BD review without confusing signals with clinical proof.
Livematching registry studies
3selected clinical phases
OfficialClinicalTrials.gov source
On loadretrieval time
Registry presence does not confirm efficacy, ownership, regulatory success, commercial value, or licensing status.
ACTIVE DEVELOPMENT SIGNALS
Phase I-III opportunities
Live public registry records
SOURCE COVERAGE
Global discovery, with the gaps visible.
ClinicalTrials.gov contains multinational studies and is refreshed by its operator on business days, but it is not exhaustive of all global registries. PharmaBridge shows what is live and what still needs integration.
EU CTIS
European Union source · not yet normalized into this library
WHO ICTRP
Global registry network · separate search and verification required
National registries
Jurisdiction-specific sources require additional data work
AUDITABLE TRIAGE
What the score means—and what it does not.
Registry facts
Phase, status, sponsor, locations, enrollment, intervention, and update date come from the official public record.
Platform signals
The priority score summarizes maturity, activity, freshness, geography, and record completeness for BD triage.
Human diligence
No score establishes efficacy, approval, valuation, freedom to operate, asset ownership, or commercial availability.